- Home
- BVFL vs HUMA Comparison
BVFL vs HUMA Comparison
Compare BVFL & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BVFL | HUMA |
|---|---|---|
| Founded | 1873 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.4M | 165.7M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BVFL | HUMA |
|---|---|---|
| Price | $21.67 | $0.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.63 |
| AVG Volume (30 Days) | 18.4K | ★ 5.6M |
| Earning Date | 10-27-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.19 | ★ 79.37 |
| EPS | ★ 0.55 | N/A |
| Revenue | N/A | ★ $2,038,000.00 |
| Revenue This Year | N/A | $72.32 |
| Revenue Next Year | N/A | $518.79 |
| P/E Ratio | $39.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.20 | $0.34 |
| 52 Week High | $22.17 | $1.90 |
Technical Indicators
Market Signals| Indicator | BVFL | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | 39.73 |
| Support Level | $20.36 | N/A |
| Resistance Level | $21.86 | $0.75 |
| Average True Range (ATR) | 0.46 | 0.04 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 85.84 | 47.46 |
Price Performance
Historical ComparisonAbout BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.